Literature DB >> 15717300

Anatomical basis of glial cell line-derived neurotrophic factor expression in the striatum and related basal ganglia during postnatal development of the rat.

Tinmarla Frances Oo1, Vincent Ries, Jinwhan Cho, Nikolai Kholodilov, Robert E Burke.   

Abstract

There is increasing evidence that glial cell line-derived neurotrophic factor (GDNF) plays a role as a limiting, striatal target-derived neurotrophic factor for dopamine neurons of the substantia nigra pars compacta (SNpc) by regulating the magnitude of the first phase of postnatal natural cell death which occurs in these neurons. While it has been shown that GDNF mRNA is relatively abundant in postnatal striatum, the cellular basis of its expression has been unknown. We therefore used nonradioactive in situ hybridization and immunohistochemistry to examine the cellular basis of GDNF mRNA and protein expression, respectively, in postnatal striatum and related structures. We found that GDNF mRNA is expressed within medium-sized striatal neurons. Expression in glia was not observed. At the protein level, regionally, GDNF expression in striatum was observed in striosomal patches, as previously described. At a cellular level a few neurons were observed, but they do not account for the striosomal pattern. This pattern is predominantly due to GDNF-positive neuropil. Some of this neuropil arises from tyrosine hydroxylase-positive nigro-striatal dopaminergic afferents. Astrocytic processes do not appear to contribute to the striosomal pattern. GDNF-positive fibers are identified not only within intrinsic striatal neuropil, but also in fibers within the major striatal efferent targets: the globus pallidus, the entopeduncular nucleus, and the SN pars reticulata. We conclude that during normal postnatal development, medium-sized neurons are the principal source of GDNF within the striatum. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717300      PMCID: PMC3092474          DOI: 10.1002/cne.20463

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  42 in total

1.  Dopaminergic neurons protected from degeneration by GDNF gene therapy.

Authors:  D L Choi-Lundberg; Q Lin; Y N Chang; Y L Chiang; C M Hay; H Mohajeri; B L Davidson; M C Bohn
Journal:  Science       Date:  1997-02-07       Impact factor: 47.728

2.  GDNF mRNA expression in normal postnatal development, aging, and in Weaver mutant mice.

Authors:  M Blum; C S Weickert
Journal:  Neurobiol Aging       Date:  1995 Nov-Dec       Impact factor: 4.673

Review 3.  The survival of developing neurons: a review of afferent control.

Authors:  R Linden
Journal:  Neuroscience       Date:  1994-02       Impact factor: 3.590

4.  Expression of the glial cell line-derived neurotrophic factor gene in rat brain after transient MCA occlusion.

Authors:  K Abe; T Hayashi
Journal:  Brain Res       Date:  1997-11-21       Impact factor: 3.252

5.  Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal glial cell line-derived neurotrophic factor in vivo.

Authors:  Tinmarla Frances Oo; Nikolai Kholodilov; Robert E Burke
Journal:  J Neurosci       Date:  2003-06-15       Impact factor: 6.167

6.  Expression of neurturin, GDNF, and their receptors in the adult mouse CNS.

Authors:  J P Golden; R H Baloh; P T Kotzbauer; P A Lampe; P A Osborne; J Milbrandt; E M Johnson
Journal:  J Comp Neurol       Date:  1998-08-17       Impact factor: 3.215

7.  Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system.

Authors:  Biljana Georgievska; Deniz Kirik; Anders Björklund
Journal:  J Neurosci       Date:  2004-07-21       Impact factor: 6.167

8.  Acute and persistent suppression of preproenkephalin mRNA expression in the striatum following developmental hypoxic-ischemic injury.

Authors:  R E Burke; S O Franklin; C E Inturrisi
Journal:  J Neurochem       Date:  1994-05       Impact factor: 5.372

9.  Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult.

Authors:  A Tomac; J Widenfalk; L F Lin; T Kohno; T Ebendal; B J Hoffer; L Olson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

10.  Regulation of the development of mesencephalic dopaminergic systems by the selective expression of glial cell line-derived neurotrophic factor in their targets.

Authors:  Nikolai Kholodilov; Olga Yarygina; Tinmarla Frances Oo; Hui Zhang; David Sulzer; William Dauer; Robert E Burke
Journal:  J Neurosci       Date:  2004-03-24       Impact factor: 6.167

View more
  12 in total

1.  Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system.

Authors:  Jun Wang; Sebastien Carnicella; Somayeh Ahmadiantehrani; Dao-Yao He; Segev Barak; Viktor Kharazia; Sami Ben Hamida; Agustin Zapata; Toni S Shippenberg; Dorit Ron
Journal:  J Neurosci       Date:  2010-10-27       Impact factor: 6.167

Review 2.  Neuronal Activity in Ontogeny and Oncology.

Authors:  Humsa Venkatesh; Michelle Monje
Journal:  Trends Cancer       Date:  2017-02-13

Review 3.  Glial modulators as potential treatments of psychostimulant abuse.

Authors:  Patrick M Beardsley; Kurt F Hauser
Journal:  Adv Pharmacol       Date:  2014

4.  Glial cell line-derived neurotrophic factor receptor-α1 expressed in striatum in trans regulates development and injury response of dopamine neurons of the substantia nigra.

Authors:  Nikolai Kholodilov; Sang Ryong Kim; Olga Yarygina; Tatyana Kareva; Jin Whan Cho; Amy Baohan; Robert E Burke
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

Review 5.  Roles of micro-opioid receptors in GABAergic synaptic transmission in the striosome and matrix compartments of the striatum.

Authors:  Masami Miura; Masao Masuda; Toshihiko Aosaki
Journal:  Mol Neurobiol       Date:  2008-05-13       Impact factor: 5.590

6.  Role of ventral tegmental area glial cell line-derived neurotrophic factor in incubation of cocaine craving.

Authors:  Lin Lu; Xi Wang; Ping Wu; Chunmei Xu; Mei Zhao; Marisela Morales; Brandon K Harvey; Barry J Hoffer; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2009-04-05       Impact factor: 13.382

Review 7.  Treatment of Parkinson's disease with trophic factors.

Authors:  Amie L Peterson; John G Nutt
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

8.  Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments.

Authors:  Jill R Crittenden; Ann M Graybiel
Journal:  Front Neuroanat       Date:  2011-09-07       Impact factor: 3.856

Review 9.  Growth Factors as Axon Guidance Molecules: Lessons From in vitro Studies.

Authors:  Massimo M Onesto; Caitlin A Short; Sarah K Rempel; Timothy S Catlett; Timothy M Gomez
Journal:  Front Neurosci       Date:  2021-05-21       Impact factor: 4.677

10.  Cellular programming and reprogramming: sculpting cell fate for the production of dopamine neurons for cell therapy.

Authors:  Julio C Aguila; Eva Hedlund; Rosario Sanchez-Pernaute
Journal:  Stem Cells Int       Date:  2012-09-04       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.